We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.99B
AUM Growth
+$203M
Cap. Flow
+$168M
Cap. Flow %
2.8%
Top 10 Hldgs %
39.68%
Holding
189
New
63
Increased
26
Reduced
35
Closed
53

Top Sells

Rank Stock Value
1
BILL icon
BILL Holdings
BILL
+$177M
2
MSFT icon
Microsoft
MSFT
+$159M
3
ADI icon
Analog Devices
ADI
+$155M
4
WIX icon
WIX.com
WIX
+$149M
5
NFLX icon
Netflix
NFLX
+$149M

Sector Composition

Rank Sector Weight
1 Technology 25.93%
2 Consumer Discretionary 9.83%
3 Communication Services 8.66%
4 Healthcare 7.99%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
101
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$5.21M 0.09%
+37,500
New +$4.68M
MDT icon
102
Medtronic
MDT
$112B
$5.01M 0.08%
40,000
-7,000
-15% -$906K
ISRG icon
103
Intuitive Surgical
ISRG
$128B
$4.97M 0.08%
15,000
-9,000
-38% -$3.02M
HZNP
104
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.93M 0.08%
45,000
-10,000
-18% -$1.04M
SYK icon
105
Stryker
SYK
$134B
$4.91M 0.08%
+18,600
New +$4.97M
NVO
106
Novo Nordisk
NVO
$228B
$4.8M 0.08%
+100,000
New +$4.83M
SGEN
107
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
$4.25M 0.07%
25,000
GILD icon
108
Gilead Sciences
GILD
$165B
$4.19M 0.07%
+60,000
New +$4.22M
AVTR icon
109
CALL
Avantor
AVTR
$9.55B
$4.09M 0.07%
+100,000
New +$3.91M
MCK icon
110
CALL
McKesson
MCK
$106B
$3.99M 0.07%
+20,000
New +$4M
BIO icon
111
Bio-Rad Laboratories Class A
BIO
$8.87B
$3.36M 0.06%
4,500
-5,500
-55% -$4.12M
COR icon
112
CALL
Cencora
COR
$62.3B
$2.99M 0.05%
+25,000
New +$3M
TMO icon
113
Thermo Fisher Scientific
TMO
$215B
$2.86M 0.05%
5,000
-5,000
-50% -$2.74M
RDNT icon
114
RadNet
RDNT
$4.94B
$2.35M 0.04%
80,000
+20,000
+33% +$642K
ALNY icon
115
Alnylam Pharmaceuticals
ALNY
$38.4B
$2.27M 0.04%
+12,000
New +$2.25M
SGRY icon
116
Surgery Partners
SGRY
$2.12B
$2.12M 0.04%
50,000
+20,000
+67% +$1.02M
PARA
117
DELISTED
Paramount Global Class B
PARA
$1.98M 0.03%
50,000
-27,000
-35% -$1.1M
DISCK
118
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$1.7M 0.03%
70,000
SONO icon
119
CALL
Sonos
SONO
$2B
$1.62M 0.03%
+50,000
New +$1.8M
SONO icon
120
Sonos
SONO
$2B
$1.62M 0.03%
+50,000
New +$1.8M
ARGX icon
121
argenx
ARGX
$55B
$1.54M 0.03%
+5,100
New +$1.62M
MRTX
122
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.54M 0.03%
+8,700
New +$1.4M
TGTX icon
123
TG Therapeutics
TGTX
$8.26B
$1.5M 0.03%
+45,000
New +$1.39M
UHS icon
124
Universal Health Services
UHS
$10.1B
$1.48M 0.02%
10,700
+700
+7% +$106K
MRNA icon
125
Moderna
MRNA
$21.8B
$1.27M 0.02%
3,300
-6,700
-67% -$2.47M

Similar funds

PointState Capital's Q3 2021 Portfolio in Review

As of Q3 2021, PointState Capital held 189 positions worth $5.99B, up 3.5% from $5.79B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PointState Capital's Q3 2021 filing shows 63 new, 26 increased, 35 reduced and 53 closed positions. Its largest new stake was Booking.com: 1,324,875 shares worth $126M. The largest sale was BILL Holdings, an estimated $177M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • PointState Capital's largest Q3 2021 buy was Booking.com: 1,324,875 shares worth $126M.
  • PointState Capital added most to Meta Platforms (Facebook) in Q3 2021, an estimated $222M increase.
  • PointState Capital's biggest Q3 2021 reduction was BILL Holdings, cutting an estimated $177M.
  • PointState Capital fully exited Analog Devices in Q3 2021, selling an estimated $155M.
  • PointState Capital's ten largest holdings make up 40% of its $5.99B portfolio in Q3 2021.
  • PointState Capital opened 63 new positions and closed 53 in Q3 2021.
  • PointState Capital's portfolio value rose 3.5% quarter-over-quarter to $5.99B.

Based on PointState Capital's 13F filing for Q3 2021, filed 15 Nov 2021.